|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Impairment related to real estate assets | |||||
| Net (gain) loss on real estate assets | |||||
| Total operating expenses | |||||
| Income from operations | |||||
| Interest (expense) income, net | |||||
| Other income (loss), net | |||||
| Income before income taxes | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Basic net income per share (in dollars per share) | |||||
| Diluted net income per share (in dollars per share) | |||||
| Weighted-average shares used in computing net income per share attributable to common stockholders, basic (in shares) | |||||
| Weighted-average shares used in computing net income per share attributable to common stockholders, diluted (in shares) |
Loading...
